T he Pediatric Heart Network's (PHN) Single Ventricle Reconstruction (SVR) trial randomized newborns with single right ventricle anomalies undergoing the Norwood procedure at 15 North American sites to either the modified Blalock-Taussig shunt (MBTS) or right ventricular-topulmonary artery shunt (RVPAS) to provide pulmonary blood flow. The primary end point, transplantation-free survival 12 months postrandomization, was significantly higher for the RVPAS compared with the MBTS group. When follow-up beyond 1 year was included, however, transplantation-free survival was not different between the 2 groups (mean followup, 32±11 months in nontransplanted survivors).
A secondary aim of the SVR trial was to compare the effect of MBTS with RVPAS on echocardiographic indices of RV function and tricuspid regurgitation (TR). Both shunt types result in RV volume overload and are often associated with hemodynamically significant TR. In addition, the RVPAS requires a right ventriculotomy, which has the potential to result in regional wall dysfunction, aneurysm formation, and dysrhythmia, all of which may negatively influence RV function. The presence of regurgitation through the RVPAS adds to RV volume overload.
Because of inherent and well-recognized difficulties in measuring single RV size and function by 2-dimensional imaging, 3-dimensional echocardiographic (3DE) analysis was incorporated into the SVR trial. Prior studies have validated the accuracy and reproducibility of both right and left ventricular volumetrics by 3DE in small hearts and at rapid heart rates, both in vivo and in vitro, and with small animals as well as humans. These studies demonstrated that 3DE analysis of ventricular size and function in young pediatric patients correlates well with MRI, albeit with a tendency for volumes to be smaller by 3DE than by MRI. [2] [3] [4] Three-dimensional echocardiographic determination of the vena contracta also provides a reliable quantitative indicator of TR. 5 Thus, for the SVR trial, 3DE was incorporated to provide serial, noninvasive analysis of RV size and function and of TR before and after the Norwood and stage II procedures. The hypothesis of the present analysis was that RV systolic function would be better and the severity of TR would be lower in subjects having the RVPAS compared with those with the MBTS.
Methods

Subjects and Echocardiographic Analyses
As previously reported, infants with single RV anomalies were randomly assigned to receive an MBTS or RVPAS during the Norwood procedure at 15 medical centers. 1 Per protocol, 3DE studies were obtained: (1) before the Norwood procedure, (2) 15.5±12.1 days after the Norwood procedure at hospital discharge, (3) 17.7±25.5 days before the stage II procedure, and (4) at 14 months after randomization (8.9±2.0 months post the stage II procedure). Ten of the 15 medical centers participating in the SVR trial contributed to the 3DE analysis. Sedation varied according to local practice. The protocol was approved by each center's Institutional Review Board, and written consent was obtained from a parent or guardian.
All centers received a training DVD developed by the SVR Trial 3DE Core Laboratory (Boston Children's Hospital, Boston, MA) to standardize 3DE acquisitions. The protocol for the 3DE acquisitions and analysis of RV size and function was based on previous reports. [2] [3] [4] Electrocardiographically gated full-volume 3DE acquisitions were performed with 2 to 4 or 5 to 7 MHz matrix array transthoracic probes and 3DE ultrasound systems (SONOS 7500 and iE33, Philips Medical Systems, Andover MA). Data sets were acquired with probe placement either in the subcostal or apical position, after ensuring that the entire ventricle could be viewed simultaneously in orthogonal planes. The probe was held motionless during a 4-beat acquisition, and the 3D volume data sets were evaluated to ensure the entire ventricle was scanned with minimal spatial and temporal artifacts. Full-volume color-flow 3DE acquisitions of the TR jet were acquired from the apex during 6 cardiac cycles. The full-volume digital gray-scale and color-flow acquisition data were transferred and stored to CD/DVD. These data, along with anthropometric and blood pressure measurements, were sent to the Data Coordinating Center (New England Research Institutes, Watertown, MA). The digital data sets were deidentified and then transferred by CD/DVD to the 3DE Core Laboratory for subsequent analysis, which was blinded to outcomes.
RV volume and mass were measured with dedicated off-line computers and software as previously described (4D Echo View, TomTec, Munich, Germany). [2] [3] [4] An image of the entire RV with clear depiction of the endocardial and epicardial borders was necessary for studies to be considered acceptable for data analysis. Each study was initially analyzed by a pediatric echocardiographic technician trained in 3DE measurements, and all measurements were confirmed by the director of the core laboratory (G.R.M.). End diastole was chosen as the largest chamber cavity size and the frame immediately before atrioventricular valve closure. End systole was chosen as the smallest chamber size and the frame before the onset of atrioventricular valve opening. Using the motion images for reference, the endocardial and epicardial borders of corresponding sequential cross-sectional planes were manually traced using the still images ( Figure 1) . A minimum of 6 discs were traced and volumes calculated by summation of discs methodology. [2] [3] [4] Ejection fraction (EF) was calculated as (EDV−ESV)/EDV, where EDV is end-diastolic volume and ESV is end-systolic volume. Myocardial mass was calculated as myocardial volume between the epicardial and endocardial borders multiplied by the myocardial density (1.05 g/mL).
TR vena contracta was measured as the smallest systolic regurgitant jet area traversing the tricuspid valve leaflets. From the 3D color-flow data sets, dedicated software (Q-lab 6.0, Philips Medical Systems, Andover, MA) provided simultaneous long-axis planes of the colorflow TR jet. From these images, a cut plane was placed perpendicular to the orthogonal long axis planes of the regurgitant jet, providing simultaneous visualization of the corresponding cross-sectional area ( Figure 2 ). This perpendicular cut plane was moved along the length of the regurgitant jet to ensure choosing the narrowest cross-sectional area, as shown in the corresponding long-and short-axis views. This cross-sectional area was manually traced and represented the area of the vena contracta. When >1 regurgitant jet was visualized, the individual vena contracta areas were summed. The vena contracta, also known as the effective tricuspid regurgitant orifice area, was recorded as a raw area measurement (centimeter squared) and then indexed to body surface area (BSA; centimeter squared per meter squared).
Statistical Analyses
Three-dimensional echo indices are shown as raw data and also indexed to BSA based on the relationship to BSA previously determined for systemic left ventricles. 6 Shunt comparisons at each trial visit were performed using the actual shunt type in place at the end of the Norwood procedure with Student t test or the Wilcoxon rank-sum test for continuous 3DE indices and a Fisher exact test for dichotomous indices. Changes in RV volumes before and after the Norwood and stage II procedures were examined with a paired t test. To examine whether 3DE indices varied by shunt type, changes in 3DE indices before and after the Norwood and stage II procedures were analyzed with Student t test. Correlations between RV end-diastolic and end-systolic volumes and tricuspid regurgitant orifice area at each trial visit were assessed with the Pearson correlation coefficient. Analyses were performed in R version 2.12.0. Two-sided P values <0.05 were considered statistically significant.
Results
A total of 549 patients (281 RVPAS and 268 MBTS) were evaluated in the trial. 1 An echocardiogram was attempted in 349 of 484 subjects (80%) at the 10 sites with 3DE capability, and ≥1 3DE was deemed acceptable by the Core Laboratory in 314 subjects (90%). In general, baseline characteristics were similar for those subjects with a 3DE versus those without a 3DE (Table 1 ). There was no statistically significant difference in shunt type between those with or without a 3DE (P=0.49). All baseline 2DE indices were similar for subjects with and without a 3DE. Hispanic ethnicity was more common in subjects with a 3DE (P=0.05), attributable to a high proportion of Hispanic patients at 1 contributing site. Obstructed pulmonary venous return was less likely in subjects with a 3DE (P=0.03). The lack of important statistically significant differences in the groups with and without a 3DE suggests that the 3DE analytic cohort is likely representative of the trial sample.
A total of 757 3DE studies were obtained across all 4 trial visits; 565 (75%) were deemed acceptable for analysis (78 before Norwood procedure, 215 at Norwood discharge, 147 before stage II operation, and 125 at month 14 after randomization). The success rate for obtaining an adequate 3DE varied from 54% to 86% (mean, 73%). Three-dimensional echocardiograms obtained at the 14-month visit were less likely to be deemed acceptable for analysis than echocardiograms obtained at previous visits (63% 
RV Size and Function
RV volume, mass (indexed to BSA), EF, and RV mass:volume ratio did not differ for the MBTS group and the RVPAS group at any trial visit (Table 2) . Considering all subjects with 3DE regardless of shunt type, there were no changes in RV EDV, ESV, mass, or EF using pairwise comparisons from preNorwood to discharge after the Norwood procedure (Table 3) . Pairwise comparisons of the pre-Norwood echo to the prestage II echo showed significant increases in RV EDV, ESV, and mass, and a significant decrease in RV EF (Table 4 ). In contrast, from the pre-stage II visit to the 14-month visit, paired comparisons showed significant decreases in RV volumes and mass, although the RV EF did not change (Table 5) .
Tricuspid Regurgitation
The severity of TR did not differ between the shunt groups at any trial visit (Table 2 ). Paired comparisons showed that TR increased for both shunt groups after the Norwood procedure (Table 3) , then remained stable in both groups thereafter (Tables 4 and 5 ). In the combined study group, RV EDV and ESV were positively associated with the tricuspid regurgitant orifice area (all parameters indexed to BSA) at all study visits except the post-Norwood visit (all P<0.01; Pearson correlation coefficients, 0.32-0.45). A small number of subjects (13/146; 9%) had concomitant tricuspid valve surgery at stage II. This number was too small to analyze the efficacy of valve repair further in reducing TR.
Discussion
The PHN SVR study is the first multicenter trial in congenital heart disease to report the use and feasibility of 3DE indices of RV volume and EF as secondary end points. This analysis does not support the study hypothesis that the RVPAS and MBTS groups would differ in 3DE measures of RV size and function and magnitude of TR. No significant difference by shunt, or indeed any clinically relevant difference by shunt, was found in any of the 3DE variables examined at any stage of repair during the first 14 months after randomization. Analysis of 2DE data from the SVR trial also suggests that RV volume and RV function do not vary between the 2 shunt types at 14 months of age. 7 It is conceivable that the 2 shunt types lead to effects on the RV that were beyond the scope of the 3DE measurements that were made. Some of these changes may include mechanical dyssynchrony or altered contraction and strain patterns. Techniques for 3DE evaluation of regional RV wall motion were unavailable at the time that this study was performed; those tools are currently in early stages of development. Differences in RV volume and function also may become manifest over a more extended period of follow-up than was present in the current study; the ongoing longitudinal evaluation of the SVR cohort should provide additional information.
Before the current study, data examining serial changes in ventricular volume, systolic function, and mass in a large number of patients with a systemic single RV were limited. This 3DE study provides insights into the remodeling of the operated single RV in the first 14 months of life, albeit with paired rather than longitudinal comparisons attributable to limitations in the number of infants with serial 3D echocardiograms. We found a significant decrease in RV diastolic and systolic volume and mass and no significant change in EF during the pre-stage II to the 14-month (preFontan) interval. Bellsham-Revell et al, 10 in a serial MRI study in a similar patient group, also recently found a significant decrease in RV diastolic volume from pre-stage II to pre-Fontan, but observed a significant increase in EF. In their study, the post-stage II MRI was done at a mean age of 2.9 years. In the current study, the post-stage II echocardiograms were obtained at a mean age of 1.2 years. Similar changes in RV volumetrics and EF may become manifest in our cohort over longer term follow-up.
Until the stage II surgery, the single RV has increased volume because it is handling cardiac output for both the pulmonary and systemic circulations. After the stage II surgery, we found significant volume unloading, but the mass:volume ratio remained the same, and the RV EF did not improve, a significant long-term concern. It is possible that remodeling may require more time than was reflected in this study. The observed decrease in indexed RV volume after stage II surgery is consistent with prior small 2DE studies by Forbes et al 11 in single left ventricles and a similar short-term study by Selamet Tierney et al 12 in patients with systemic left or right ventricles. In a 3DE study of 18 patients with hypoplastic left heart syndrome, Kutty et al 13 reported a nonsignificant decrease in RV volume after the stage II surgery and also found deterioration in the RV EF, consistent with our findings. An acute decrease in EF is the expected response to the preload reduction as a result of the volume unloading surgery and does not necessarily imply myocardial injury because recovery of function generally occurs after myocardial reverse remodeling is complete.
It is commonly thought that a decrease in RV volumes after the stage II procedure will result in a reduction in the magnitude of TR. However, in this study, TR did not decrease between the post-Norwood study and the 14-month study, which is sufficiently beyond the stage II operation to have allowed for changes in tricuspid valve function in response to any RV remodeling resulting from volume unloading. This suggests that the demonstrated volume decrease after the stage II procedure may not lead to decreased TR and that RV volume overload is not the sole factor responsible for the development of TR in this cohort of patients. Only 4 patients in the 3DE cohort had tricuspid valve surgery at stage II, so the efficacy of valve repair in reducing TR could not be assessed. The MRI study by Bellsham-Revell et al 10 also found no improvement in TR despite RV volume reduction after the stage II procedure.
The location, complex anatomy, and irregular shape of the RV pose a challenge to traditional imaging. The RV has complex contraction patterns, with its inflow and sinus exhibiting shortening primarily in a longitudinal direction, whereas the outflow tract contracts primarily in a circumferential manner.
14 The accuracy of 3DE RV volumetrics compared with MRI has been well established across a range of patient sizes (ranging from children to adults), both in normal populations and in disease states ranging from tetralogy of Fallot to univentricular hearts. 2, [15] [16] [17] [18] [19] [20] [21] In anticipation of this multicenter trial, the Core Laboratory, Boston Children's Hospital, performed in vitro and in vivo studies to evaluate the reliability of 3DE to measure RV volumes, mass, and EF in this young pediatric age group similar to that encountered in this multicenter trial. 2, 3 The findings showed good correlation for diastolic and systolic volumes and RV mass. However, RV volumes by 3DE were consistently smaller by 9%. Herberg et al 22 compared 3DE volumes with small, calibrated, tissue-mimicking phantoms. Although the authors concluded that 3DE was a reliable method for calculation of small distances, areas, and volumes, 3D echo volume measurements were consistently smaller. Similar to findings by Hoch et al, 4 both compress and gain settings significantly affected 3DE measurements.
The Core Laboratory addressed inter-and intraobserver variability in both in vitro 4 and in vivo studies. 2, 3 The in vivo studies included comparisons to MRI as the gold standard. Soriano et al, 2 in their study comparing 3DE with MRI in young infants with single ventricles, reported good correlation and agreement for intraobserver variability. Diastolic volume, systolic volume, and mass correlated and agreed well for interobserver variability. The intraclass coefficient for EF was 0.75, and the mean difference was 0.04. Although this was statistically significant (P<0.02), the difference is small and thus not clinically significant.
For this multicenter trial, only studies with clear delineation of endocardial borders and in which the entire RV was included in the data set were accepted for mass and volume measurements. Although this rigorous threshold may in part be responsible for the lower feasibility rate of 75%, it should have contributed to the high standards for repeatability.
In a recent consensus document from the American Society of Echocardiography and the European Association of Echocardiography, 23 the authors highlight the potential role of 3DE assessment of RV volumes and EF in postoperative patients. Despite the theoretical desirability of 3DE for the RV, however, it was difficult to obtain adequate images at all study visits, and there was considerable variability by site. Overall, the success rate declined as the subjects got older, regardless of sedation use. Recent technological advances, such as smaller transducers, improved temporal and spatial resolution of images, single-beat acquisitions, and advanced regional analysis of ventricular function, are likely to improve the success of acquiring adequate 3DE images in complex congenital heart disease. In particular, frame reordering may significantly increase 3DE temporal resolution, which is seminal in improving measurements in young patients with high heart rates. 24 
Limitations
This study should be interpreted in light of its limitations. Overall, 75% of acquisitions were acceptable for data analysis, but the success rate varied widely by site. Therefore, statistical power to detect differences in RV size and function was limited compared with analyses of the trial's 2D echo database. The variability in success also meant that many subjects did not have studies at multiple time points, thus necessitating paired comparisons at individual time points rather than longitudinal modeling. The cause of unacceptable data likely relates in part to suboptimal acoustic windows attributable to increasing age and the history of repeated sternotomy and in part to the inability to control respirations. Younger patients were more likely to have acceptable images, lending some credence to this view. Recent technological advances, not available at the time of the study, might have enhanced the proportion of acceptable studies. We also recognize the limitations inherent in the absence of validation data from MRI for the 3DE quantification of TR in infants with hypoplastic left heart syndrome, but thought the measures systematically obtained in this study provide useful data in this population.
Conclusions
The PHN SVR trial is the first multicenter effort in congenital heart disease to report the use and feasibility of 3DE indices of RV volume and EF as secondary end points. RV size and function, and severity of TR, as measured by 3DE, are not different between RVPAS and MBTS patient groups from before the Norwood procedure until 14 months of age. The stage II operation results in a decrease in indexed RV volumes and mass, but the magnitude of TR does not decrease, and EF remains persistently low.
